PubMed

Response to sunitinib in medullary thyroid cancer.

Kelleher FC, McDermott R.

Ann Intern Med. 2008 Apr 1;148(7):567. No abstract available. PMID: 18378960 [PubMed - indexed for MEDLINE]Related articlesFree article

Medullary thyroid cancer: targeting the RET kinase pathway with sorafenib/tipifarnib.

Hong D, Ye L, Gagel R, Chintala L, El Naggar AK, Wright J, Kurzrock R.

Mol Cancer Ther. 2008 May;7(5):1001-6. Epub 2008 Apr 29.PMID: 18445656 [PubMed - indexed for MEDLINE]Related articlesFree article

Apoptotic cell death induction and angiogenesis inhibition in large established medullary thyroid carcinoma xenografts by Ret inhibitor RPI-1.

Petrangolini G, Cuccuru G, Lanzi C, Tortoreto M, Belluco S, Pratesi G, Cassinelli G, Zunino F.

Biochem Pharmacol. 2006 Aug 14;72(4):405-14. Epub 2006 Jun 6.PMID: 16756963 [PubMed - indexed for MEDLINE]Related articles

Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma.

Dawson SJ, Conus NM, Toner GC, Raleigh JM, Hicks RJ, McArthur G, Rischin D.

Anticancer Drugs. 2008 Jun;19(5):547-52.PMID: 18418222 [PubMed - indexed for MEDLINE]Related articles

Re: "Inhibition of medullary thyroid carcinoma (MTC) cell proliferation and RET phosphorylation by tyrosine kinase inhibitors".

Plaza Menacho I, de Groot JW, Links T, Plukker J, Eggen BJ, Hofstra R.

Surgery. 2004 Feb;135(2):240-1; author reply 241. No abstract available. PMID: 14760839 [PubMed - indexed for MEDLINE]Related articles

Advances in chemotherapy of differentiated epithelial and medullary thyroid cancers.

Sherman SI.

J Clin Endocrinol Metab. 2009 May;94(5):1493-9. Epub 2009 Mar 3. Review.PMID: 19258410 [PubMed - indexed for MEDLINE]Related articles

Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates.

Morisi R, Celano M, Tosi E, Schenone S, Navarra M, Ferretti E, Costante G, Durante C, Botta G, D'Agostino M, Brullo C, Filetti S, Botta M, Russo D.

J Endocrinol Invest. 2007 Nov;30(10):RC31-4.PMID: 18075281 [PubMed - indexed for MEDLINE]Related articles

Complete cerebral response with sunitinib for metastatic renal cell carcinoma.

Medioni J, Cojocarasu O, Belcaceres JL, Halimi P, Oudard S.

Ann Oncol. 2007 Jul;18(7):1282-3. No abstract available. PMID: 17675397 [PubMed - indexed for MEDLINE]Related articlesFree article

Sunitinib therapy in renal cell carcinoma.

O'Brien MF, Russo P, Motzer RJ.

BJU Int. 2008 Jun;101(11):1339-42. Epub 2008 Feb 18. Review. No abstract available. PMID: 18284408 [PubMed - indexed for MEDLINE]Related articles

[Sunitinib versus interferon-alpha in metastatic renal-cell carcinoma]

Irani J.

Prog Urol. 2007 Sep;17(5):996. French. No abstract available. PMID: 17969805 [PubMed - indexed for MEDLINE]Related articles

F-18 FDG PET/CT assessment of gastrointestinal stromal tumor response to sunitinib malate therapy.

Banzo I, Quirce R, Martinez-Rodriguez I, Jimenez-Bonilla J, Sainz-Esteban A, Barragan J, Portilla-Quattrociocchi H, Carril JM.

Clin Nucl Med. 2008 Mar;33(3):211-2. No abstract available. PMID: 18287850 [PubMed - indexed for MEDLINE]Related articles

[News on ASCO 2007. Sunitinib in the treatment of metastatic renal carcinoma and gastrointestinal stromal tumors.]

Mansueto G, Longo F.

Tumori. 2007 Sep-Oct;93(5):Suppl 1-16. Italian. No abstract available. PMID: 18038894 [PubMed - indexed for MEDLINE]Related articles

Sunitinib and the benefits of a negative study.

Forner A, Llovet JM, Bruix J.

Lancet Oncol. 2009 Aug;10(8):743-4. Review. No abstract available. PMID: 19647195 [PubMed - indexed for MEDLINE]Related articles

Sunitinib-associated lymphocytic thyroiditis without circulating antithyroid antibodies.

Alexandrescu DT, Popoveniuc G, Farzanmehr H, Dasanu CA, Dawson N, Wartofsky L.

Thyroid. 2008 Jul;18(7):809-12. No abstract available. PMID: 18631016 [PubMed - indexed for MEDLINE]Related articles

Invited commentary: medullary thyroid cancer: the importance of RET testing.

Evans DB, Shapiro SE, Cote GJ.

Surgery. 2007 Jan;141(1):96-9. No abstract available. PMID: 17188173 [PubMed - indexed for MEDLINE]Related articles

Sunitinib malate as the salvage therapy in advanced rectal carcinoid tumor.

Lu CC, Lin HF, Feng CC, Yu CY, Kao WY.

Int J Colorectal Dis. 2008 Dec;23(12):1265-6. Epub 2008 Jul 16. No abstract available. PMID: 18629516 [PubMed - indexed for MEDLINE]Related articles

Patient with malignant paraganglioma responding to the multikinase inhibitor sunitinib malate.

Hahn NM, Reckova M, Cheng L, Baldridge LA, Cummings OW, Sweeney CJ.

J Clin Oncol. 2009 Jan 20;27(3):460-3. Epub 2008 Dec 8. No abstract available. PMID: 19064958 [PubMed - indexed for MEDLINE]Related articles

Acute hepatic failure following monotherapy with sunitinib for ovarian cancer.

Taran A, Ignatov A, Smith B, Costa SD, Bischoff J.

Cancer Chemother Pharmacol. 2009 Apr;63(5):971-2. Epub 2008 Aug 21. No abstract available. PMID: 18716778 [PubMed - indexed for MEDLINE]Related articles

Remission of diabetes while on sunitinib treatment for renal cell carcinoma.

Templeton A, Brändle M, Cerny T, Gillessen S.

Ann Oncol. 2008 Apr;19(4):824-5. Epub 2008 Mar 6. No abstract available. PMID: 18326519 [PubMed - indexed for MEDLINE]Related articlesFree article

Sunitinib for treatment of advanced renal cell cancer: primary tumor response.

van der Veldt AA, Meijerink MR, van den Eertwegh AJ, Bex A, de Gast G, Haanen JB, Boven E.

Clin Cancer Res. 2008 Apr 15;14(8):2431-6.PMID: 18413834 [PubMed - indexed for MEDLINE]Related articlesFree article